← SynDRA
CL-82198
SynDRA canonical compound SYN0061694 — structure-anchored drug synonym record
| Primary target(s) | MMP13 |
|---|
| Mechanism of action | Metalloproteinase inhibitor |
|---|
All known targets
Mechanisms of action (all sources)
- Metalloproteinase inhibitor
- MMP13 INHIBITOR
Bioactivity evidence (ChEMBL activities table — not curator-asserted)
Cross-references
Synonyms
- CL82198
- N-[4-(morpholin-4-yl)butyl]-1-benzofuran-2-carboxamide
- N-(4-(morpholin-4-yl)butyl)-1-benzofuran-2-carboxamide
- RefChem:126673
- CL 82198
- N-(4-morpholinobutyl)benzofuran-2-carboxamide
- 2-Benzofurancarboxamide, N-[4-(4-morpholinyl)butyl]-
- Benzofuran-2-carboxylic acid (4-morpholin-4-yl-butyl)-amide
- MFCD12828877
- N-[4-(4-Morpholinyl)butyl]-2-benzofurancarboxamide
- MLS006011944
- GTPL5170
- orb1308445
- SCHEMBL8343274
- SCHEMBL29677250
- CHEBI:92019
- GLXC-20478
- BDBM50149234
- EBC-09165
- AKOS032953784
- CS-5812
- NCGC00167801-01
- NCGC00167801-05
- AS-76783
- DA-62371
- SMR004676625
- CL-82198?
- HY-100359
- CL-82198, >=98% (HPLC), powder
- E85234
- T14978
- F475797
- BRD-K00675675-003-01-2
- Z435160380
Look up CL-82198 in the interactive SynDRA portal →